Pablo A. Gaspar, M.D. Ph.D.

Affiliations: 
Universidad de Chile, Santiago, Región Metropolitana, Chile 
Area:
Cognitive Neuroscience
Google:
"Pablo A Gaspar"
Mean distance: 14.56 (cluster 29)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gaspar PA, Castillo RI, Maturana A, et al. (2018) Early psychosis detection program in Chile: A first step for the South American challenge in psychosis research. Early Intervention in Psychiatry
Martínez A, Gaspar PA, Hillyard SA, et al. (2018) Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications. The American Journal of Psychiatry. appiajp201818010072
Bustamante ML, Herrera L, Gaspar PA, et al. (2017) Shifting the focus toward rare variants in schizophrenia to close the gap from genotype to phenotype. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 174: 663-670
Castillo RI, Rojo LE, Henriquez-Henriquez M, et al. (2016) From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism. Frontiers in Neuroscience. 10: 488
Rojo LE, Gaspar PA, Silva H, et al. (2015) Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology. Pharmacological Research. 101: 74-85
Martínez A, Gaspar PA, Hillyard SA, et al. (2015) Neural oscillatory deficits in schizophrenia predict behavioral and neurocognitive impairments. Frontiers in Human Neuroscience. 9: 371
Rojo LE, Gaspar PA, Silva H, et al. (2015) Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology Pharmacological Research
Gaspar PA, Bustamante ML, Rojo LE, et al. (2012) From glutamatergic dysfunction to cognitive impairment: boundaries in the therapeutic of the schizophrenia. Current Pharmaceutical Biotechnology. 13: 1543-8
Gaspar PA, Bosman CA, Ruiz S, et al. (2011) Parametric increases of working memory load unveil a decreased alpha oscillatory activity in schizophrenia. Schizophrenia Research. 131: 268-9
Rojo LE, Gaspar PA, Maccioni RB. (2011) Molecular targets in the rational design of AD specific PET tracers: tau or amyloid aggregates? Current Alzheimer Research. 8: 652-8
See more...